Should You Buy Bristol Myers Squibb While It Trades Below 10 Times Forward Earnings?

The Motley Fool | Oct 25, 2026 5:35 PM EDT

Key PointsBristol Myers Squibb is set to lose patent protections on two blockbuster drugs.